Silencing of hSlo potassium channels in human osteosarcoma cells promotes tumorigenesis

International Journal of Cancer

Volumn 123, Issue 2, 2008, Pages 365-371

  Cambien, Béatrice ^a,b   Rezzonico, Roger ^a,b   Vitale, Sébastien ^a,b   Rouzaire Dubois, Béatrice ^c   Dubois, Jean Marc ^c   Barthel, Robert ^a,b   Soilihi, Babou Karimdjee ^a,b,d   Mograbi, Baharia ^a,b   Schmid Alliana, Annie ^a,b   Schmid Antomarchi, Heidy ^a,b  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b INSERM   (France)

^c LABORATOIRE DE NEUROBIOLOGIE CELLULAIRE ET MOLÉCULAIRE   (France)

^d CENTRE HOSPITALIER UNIVERSITAIRE DE NICE   (France)

Author keywords

Chemokines; Ion channels; Osteosarcoma; Tumor microenvironment; Xenografts

Indexed keywords

CHEMOKINE; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; KCNMA1 PROTEIN, HUMAN; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNIT; SMALL INTERFERING RNA;

ALPHA CHAIN; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; GENE EXPRESSION REGULATION; GENE SILENCING; HUMAN; HUMAN CELL; IN VIVO STUDY; LEUKOCYTE MIGRATION; MICROENVIRONMENT; MOUSE; NONHUMAN; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; RNA INTERFERENCE; TUMOR PROMOTION; BONE TUMOR; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENETICS; METABOLISM; NORTHERN BLOTTING; PLASMID; POLYMERASE CHAIN REACTION; TUMOR CELL LINE;

BLOTTING, NORTHERN; BONE NEOPLASMS; CELL LINE, TUMOR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNEL ALPHA SUBUNITS; OSTEOSARCOMA; PLASMIDS; POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, SMALL INTERFERING;

EID: 44949121613     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.23511     Document Type: Article

References (41)

1. Kunzelmann K. Ion channels and cancer. J Membr Biol 2005;205:159-73.
2. + channels in rat skeletal muscle. J Physiol 1991;443:739-77.
3. Weiger TM, Hermann A, Levitan IB. Modulation of calcium-activated potassium channels. J Comp Physiol A Neuroethol Sens Neural Behav Physiol 2002;188:79-87.
4. Weaver AK, Liu X, Sontheimer H. Role for calcium-activated potassium channels (BK) in growth control of human malignant glioma cells. J Neurosci Res 2004;78:224-34.
5. Peers C, Kemp PJ. Ion channel regulation by chronic hypoxia in models of acute oxygen sensing. Cell Calcium 2004;36:341-8.
6. Rezzonico R, Cayatte C, Bourget-Ponzio I, Romey G, Belhacene N, Loubat A, Rocchi S, Van Obberghen E, Girault JA, Rossi B, Schmid-Antomarchi H. Focal adhesion kinase pp125FAK interacts with the large conductance calcium-activated hSlo potassium channel in human osteoblasts: potential role in mechanotransduction. J Bone Miner Res 2003;18:1863-71.
7. Gribkoff VK, Starrett JE, Jr, Dworetzky SI. Maxi-K potassium channels: form, function, and modulation of a class of endogenous regulators of intracellular calcium. Neuroscientist 2001;7:166-77.
8. + channels: function, pharmacology and drugs. Curr Med Chem 2002;9:1385-95.
9. + secretion and localization of molecular components. Am J Physiol Renal Physiol 2006;291:F517-29
10. + channels:physiological role and pharmacology. Curr Med Chem 2003;10:649-61.
11. Weaver AK, Bomben VC, Sontheimer H. Expression and function of calcium-activated potassium channels in human glioma cells. Glia 2006;54:223-33.
12. Rezzonico R, Schmid-Alliana A, Romey G, Bourget-Ponzio I, Breuil V, Breittmayer V, Tartare-Deckert S, Rossi B, Schmid-Antomarchi H. Prostaglandin E2 induces interaction between hSlo potassium channel and Syk tyrosine kinase in osteosarcoma cells. J Bone Miner Res 2002;17:869-78.
13. Arndt CA, Crist WM. Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 1999;341:342-52.
14. Tsuchiya H, Kanazawa Y, Abdel-Wanis ME, Asada N, Abe S, Isu K, Sugita T, Tomita K. Effect of timing of pulmonary metastases identification on prognosis of patients with osteosarcoma: the Japanese Musculoskeletal Oncology Group study. J Clin Oncol 2002;20:3470-7.
15. Pallanck L, Ganetzky B. Cloning and characterization of human and mouse homologs of the Drosophila calcium-activated potassium channel gene, slowpoke. Hum Mol Genet 1994;3:1239-43.
16. Rochet N, Dubousset J, Mazeau C, Zanghellini E, Farges MF, de Novion HS, Chompret A, Delpech B, Cattan N, Frenay M, Gioanni J. Establishment, characterisation and partial cytokine expression profile of a new human osteosarcoma cell line (CAL 72). Int J Cancer 1999;82:282-5.
17. Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001;411:494-8.
18. Vitale S, Cambien B, Karimdjee BF, Barthel R, Staccini P, Luci C, Breittmayer V, Anjuere F, Schmid-Alliana A, Schmid-Antomarchi H. Tissue-specific differential antitumour effect of molecular forms of fractalkine in a mouse model of metastatic colon cancer. Gut 2007;56:365-72.
19. Rouzaire-Dubois B, O'Regan S, Dubois JM. Cell size-dependent and independent proliferation of rodent neuroblastoma x glioma cells. J Cell Physiol 2005;203:243-50.
20. Dworetzky SI, Trojnacki JT, Gribkoff VK. Cloning and expression of a human large-conductance calcium-activated potassium channel. Brain Res Mol Brain Res 1994;27:189-93.
21. Editorial Board. Whither RNAi? Nat Cell Biol 2003;5:489-90.
22. +channels in the regulatory volume decrease in human osteoblast-like cells. J Membr Biol 2000;178:11-20.
23. Barry EL. Expression of mRNAs for the alpha 1 subunit of voltagegated calcium channels in human osteoblast-like cell lines and in normal human osteoblasts. Calcif Tissue Int 2000;66:145-50.
24. Caffrey JM, Farach-Carson MC. Vitamin D3 metabolites modulate dihydropyridine-sensitive calcium currents in clonal rat osteosarcoma cells. J Biol Chem 1989;264:20265-74.
25. Guggino SE, Lajeunesse D, Wagner JA, Snyder SH. Bone remodeling signaled by a dihydropyridine- and phenylalkylamine-sensitive calcium channel. Proc Natl Acad Sci USA 1989;86:2957-60.
26. Slettenaar VI, Wilson JL. The chemokine network: a target in cancer biology? Adv Drug Deliv Rev 2006;58:962-74.
27. Bruserud O, Tronstad KJ, Berge R. In vitro culture of human osteosarcoma cell lines: a comparison of functional characteristics for cell lines cultured in medium without and with fetal calf serum. J Cancer Res Clin Oncol 2005;131:377-84.
28. 2+-dependent and -independent pathways. Mol Cell Endocrinol 2002;192:27-36.
29. + secretion through multiple KCa-type channels and regulation by IKCa channels in rat proximal colon. Am J Physiol Gastrointest Liver Physiol 2003;285:G185-96.
30. Turnheim K, Plass H, Wyskovsky W. Basolateral potassium channels of rabbit colon epithelium: role in sodium absorption and chloride secretion. Biochim Biophys Acta 2002;1560:51-66.
31. Lu R, Alioua A, Kumar Y, Eghbali M, Stefani E, Toro L. MaxiK channel partners: physiological impact. J Physiol 2006;570:65-72.
32. Bloch M, Ousingsawat J, Simon R, Schraml P, Gasser TC, Mihatsch MJ, Kunzelmann K, Bubendorf L. KCNMA1 gene amplification promotes tumor cell proliferation in human prostate cancer. Oncogene 2007;26:2525-34.
33. + channels in breast cancer cells. Biochem Biophys Res Commun 2004;316:244-51.
34. Vicari AP, Caux C. Chemokines in cancer. Cytokine Growth Factor Rev 2002;13:143-54.
35. Grigolo B, Roseti L, Lisignoli G, Remiddi G, Facchini A. Expression of different chemokines by human osteosarcoma cells in response to tumor necrosis factor-alpha. Anticancer Res 1999;19:3093-8.
36. Colomar A, Marty V, Medina C, Combe C, Parnet P, Amedee T. Maturation and release of interleukin-1beta by lipopolysaccharide-primed mouse Schwann cells require the stimulation of P2X7 receptors. J Biol Chem 2003;278:30732-40.
37. Scheel O, Papavlassopoulos M, Blunck R, Gebert A, Hartung T, Zahringer U, Seydel U, Schromm AB. Cell activation by ligands of the toll-like receptor and interleukin-1 receptor family depends on the function of the large-conductance potassium channel MaxiK in human macrophages. Infect Immun 2006;74:4354-6.
38. Mantovani A. Chemokines in neoplastic progression. Semin Cancer Biol 2004;14:147-8.
39. Monti P, Leone BE, Marchesi F, Balzano G, Zerbi A, Scaltrini F, Pasquali C, Calori G, Pessi F, Sperti C, Di Carlo V, Allavena P, et al. The CC chemokine MCP-1/CCL2 in pancreatic cancer progression: regulation of expression and potential mechanisms of antimalignant activity. Cancer Res 2003;63:7451-61.
40. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006;66:605-12.
41. Talmadge JE, Uithoven KA, Reif AE. Relationship of macrophage content, immunogenicity, and metastatic potential of a murine osteosarcoma of recent origin. Clin Exp Metastasis 1985;3:61-72.